SAN JOSE, Calif.–(BUSINESS WIRE)– #WeConnect–Credo launches 800G ZeroFlap optical transceivers engineered for AI networks.
Category: News
US FDA Declines to Approve Aldeyra’s Eye Disorder Drug, Shares Slump
The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics’ drug for a type of eye disease, the company said on Tuesday, sending its shares plunging… Reuters Health Information
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete…
When Hearing Fails, Vision Rehab Falls Short
Patients with hearing impairment who receive vision rehabilitation are 42% less likely than those with normal hearing to achieve a meaningful functional improvement, a recent study shows. Medscape Medical News
Change Healthcare Breach Still Affecting Docs, Hospitals
Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024. Medscape Medical News
Motor Impairments Tied to Dementia Risk
Impairments in vision and motor functions are linked to an increased risk of developing dementia among older adults. Medscape Medical News
Which Allergens Trigger Contact Dermatitis in HCPs?
Occupational contact dermatitis affects North American healthcare workers and is commonly linked to glove rubber accelerators, surfactants, and preservatives, a retrospective study finds. Medscape Medical News
Genomics and AI Will Up Precision of Glaucoma Care
Polygenic risk scores in development for glaucoma could usher in more personalized estimates of risk. Medscape Medical News
A Novel Device to Slow Myopia in Children
Newly approved lenses are a game changer for myopia, reducing the development of nearsightedness in children. Medscape Ophthalmology
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo
MIAMI–(BUSINESS WIRE)– #AIPoweredVisionDiagnostics–Heru, the leader in AI-powered vision diagnostics, announced it is showcasing the new PretestPro on its Heru wearable platform at Vision Expo 2026.
Light Therapy May Improve Vision in Patients With Dry AMD
Light therapy with multiple wavelengths may safely improve vision, reduce new retinal damage, and improve vision related quality of life in patients with dry age related macular degeneration. Medscape Medical News
Cosmetic Eyelash Extensions Raise Eye Safety Concerns
Eyelash extensions may contribute to blepharitis, dry eye disease, and corneal injury through meibomian gland dysfunction. Medscape News Australia
Spanish Researchers Develop Low-cost Artificial Cornea From Fish Scales
Researchers at Spain’s University of Granada have developed an artificial cornea made from the scales of several fish species commonly found in markets, which could become… Reuters Health Information
Streaming Medical Series That Docs Love
A new wave of streaming shows has replaced medical soap operas with the gritty, realistic stressors of modern medicine. Which ones do doctors like? Medscape
Common Glaucoma Med May Undermine Trabeculectomy Success
Topical brimonidine is linked to a significantly increased risk for trabeculectomy failure in patients with glaucoma due to elevated intraocular pressure. Medscape Medical News
GenSight Biologics fait le point sur les programmes d’accès précoce de GS010/LUMEVOQ® et sur l’étude REVISE en cours
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (« GenSight Biologics » ou la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique en phase clinique, spécialisée dans le développement et la comme…
GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Could Blood Pressure Meds Worsen Glaucoma Damage?
Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure. Medscape Medical News
Pediatric Rheumatologist Explains Updated ACR JIA Guidelines
The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS. Medscape Medical News